Olivier Loria

ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia

Januario E. Castro, Carlos E. Prada, Olivier Loria et al. · Blood · 2005 · 121 citations · Full text

Life Sciences, Molecular Biology, Oncology +12

AT-101, a small molecule Bcl-2 antagonist, in treatment naïve CLL patients (pts) with high risk features; Preliminary results from an ongoing phase I trial

Danelle F. James, Januario E. Castro, Olivier Loria et al. · Journal of Clinical Oncology · 2006 · 41 citations

Medicine, Oncology, Pharmacology +13

Uveitis as an Open Window to Systemic Inflammatory Diseases

Thomas El Jammal, Olivier Loria, Yvan Jamilloux et al. · Journal of Clinical Medicine · 2021 · 36 citations · Full text

Medicine, Ophthalmology, Autoimmunity +13

A Phase II, Open Label Study of AT-101 in Combination with Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia. Evaluation of Two Dose Regimens.

Januario E. Castro, Olivier Loria, Robier A. Aguillon et al. · Blood · 2007 · 30 citations

Medicine, Oncology, Pharmacotherapy +15

QUANTITATIVE ANALYSIS OF CHORIOCAPILLARIS ALTERATIONS IN SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY-ANGIOGRAPHY DURING RADIATION RETINOPATHY

Christelle Gilli, Laurent Kodjikian, Olivier Loria et al. · Retina · 2022 · 20 citations

Medicine, Ophthalmology, Radiation Oncology +17